Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gionata Fiorino

Showing results (1-10 of 294) with videos related to

Pageof 30
Sort By:
Journal of Crohn'S & Colitis|May 17, 2021
At the Crossroads of Caution and Intervention: Anti-TNF Therapy Prior to Elective CD SurgeryMichel Adamina, Gionata Fiorino
Gastroenterology|December 3, 2014
Etrolizumab in ulcerative colitis: tightening leukocyte traffic control in the inflamed mucosaGionata Fiorino, Silvio Danese
Digestive Diseases and Sciences|September 18, 2016
Diagnostic Delay in Crohn's Disease: Time for Red FlagsGionata Fiorino, Silvio Danese
Best Practice & Research. Clinical Gastroenterology|June 11, 2014
The biosimilar road in inflammatory bowel disease: the right way?Gionata Fiorino, Silvio Danese
United European Gastroenterology Journal|July 10, 2021
The new frontier: Certifying quality standards in the inflammatory bowel disease careGionata Fiorino, Silvio Danese
Journal of Crohn'S & Colitis|July 9, 2016
Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond?Gionata Fiorino, Silvio Danese
Current Medicinal Chemistry|May 15, 2018
Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's ProfileSilvio Danese, Gionata Fiorino
Expert Review of Clinical Immunology|April 6, 2013
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease--an updateMonica Cesarini, Gionata Fiorino
Journal of Crohn'S & Colitis|June 17, 2015
Psoriasis and Inflammatory Bowel Disease: Two Sides of the Same Coin?Gionata Fiorino, Paolo D Omodei
United European Gastroenterology Journal|January 22, 2022
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?Ferdinando D'Amico, Alessandra Zilli, Gionata Fiorino
Pageof 30

Showing results (1-10 of 294) with videos related to

Sort By:
Pageof 30
Journal of Crohn'S & Colitis|May 17, 2021
At the Crossroads of Caution and Intervention: Anti-TNF Therapy Prior to Elective CD SurgeryMichel Adamina, Gionata Fiorino
Gastroenterology|December 3, 2014
Etrolizumab in ulcerative colitis: tightening leukocyte traffic control in the inflamed mucosaGionata Fiorino, Silvio Danese
Digestive Diseases and Sciences|September 18, 2016
Diagnostic Delay in Crohn's Disease: Time for Red FlagsGionata Fiorino, Silvio Danese
Best Practice & Research. Clinical Gastroenterology|June 11, 2014
The biosimilar road in inflammatory bowel disease: the right way?Gionata Fiorino, Silvio Danese
United European Gastroenterology Journal|July 10, 2021
The new frontier: Certifying quality standards in the inflammatory bowel disease careGionata Fiorino, Silvio Danese
Journal of Crohn'S & Colitis|July 9, 2016
Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond?Gionata Fiorino, Silvio Danese
Current Medicinal Chemistry|May 15, 2018
Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's ProfileSilvio Danese, Gionata Fiorino
Expert Review of Clinical Immunology|April 6, 2013
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease--an updateMonica Cesarini, Gionata Fiorino
Journal of Crohn'S & Colitis|June 17, 2015
Psoriasis and Inflammatory Bowel Disease: Two Sides of the Same Coin?Gionata Fiorino, Paolo D Omodei
United European Gastroenterology Journal|January 22, 2022
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?Ferdinando D'Amico, Alessandra Zilli, Gionata Fiorino
Pageof 30